| 2918.19.12 | 00 | Phenylglycolic acid (Mandelic acid), its salts and esters: | | | | |
| 2921.59.08 | 00 | 5-Amino-2-(p-aminoanilino)benzenesulfonic acid; 4,4'-Diamino-3-biphenylsulfonic acid (3-Benzidinesulfonic acid); 3,3'-Dimethylbenzidine (o-Tolidine); 3,3'-Dimethylbenzidine hydrochloride; Ethyl-(2-dimethylaminoethyl)aniline; N-Ethyl-N,N'-dimethyl-N'-phenylethylene- diamine; and 4,4'-Methylenebis(2-chloroaniline) | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,L,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2923 | | Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined: | | | | |
| 2923.10.00 | 00 | Choline and its salts | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2923.20 | | Lecithins and other phosphoaminolipids: | | | | |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2930.90.49 | 10 | Thioglycolic acid | kg | | | |
| 2933.19.04 | 00 | Aminomethylphenylpyrazole (Phenylmethylaminopyrazole); and 3-Methyl-1-(p-tolyl)-2-pyrazolin-5-one (p-Tolyl methyl pyrazolone) | kg | Free | | 15.4￠/kg + 39.5% |
| 2933.19.08 | 00 | 3-(5-Amino-3-methyl-1H-pyrazol-1-yl)- benzenesulfonic acid; Amino-J-pyrazolone; 3-Amino-1-(2,4,6-trichlorophenyl)-5- pyrazolone; 3-Carboxy-1,4-sulfophenylpyrazol-5-one; 4-Chloro-3-(3-methyl-5-oxo-2-pyrazolin-1- yl)benzenesulfonic acid; 1-(m-Chlorophenyl)-3-methyl-2-pyrazolin- 5-one; p-Chloropyrazolone; 1-(2',5'-Dichlorophenyl)-3-methyl-2- pyrazolin-5-one; 1-(o-Ethylphenyl)-3-methyl-2-pyrazolin- 5-one; 5-Imino-3-methyl-1-phenylpyrazole; 5-Imino-3-methyl-1-(m-sulfophenyl)- pyrazole; 2,4-Methylcarboxypyrazolic acid; Methylphenylpyrazolone; and Sulfinpyrazone | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.19.15 | 00 | 1,2-Dimethyl-3,5-diphenyl-1H-pyrazolium methyl sulfate (Difenzoquat methyl sulfate) | kg | Free | | 15.4￠/kg + 48.5% |
| 2933.19.18 | 00 | 2-Chloro-5-sulfophenylmethylpyrazolone; 2,5-Dichloro-4-(3-methyl-5-oxo-2- pyrazolin-1-yl) benzenesulfonic acid; Phenylcarbethoxypyrazolone; m-Sulfaminopyrazolone (m-Sulfamido- phenylmethylpyrazolone); and 1-(p-Sulfophenyl)-3-methylpyrazolone | kg | Free | | 15.4￠/kg + 52% |
| 2933.39.10 | 00 | Collidines, lutidines and picolines | kg | Free | | Free |
| 2933.39.20 | 00 | p-Chloro-2-benzylpyridine; 4-Chloro-1-methylpiperidine hydrochloride; 1,4-Dimethyl-6-hydroxy-3-cyanopyrid-2-one; Di-(2,2,6,6-tetramethyl-4-hydroxy- piperidine)sebacate; 2-Methyl-5-ethylpyridine; 4-Phenylpropylpyridine; α-Phenylpyridylacetic acid, methyl ester; Picolinic acid; 2-Pyridinecarboxaldehyde; and 2,5-Pyridinedicarboxylic acid | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.41.00 | 00 | Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2933.49.08 | 00 | 4,7-Dichloroquinoline | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2￠/kg + 3.1% (SG) | 15.4￠/kg + 52% |
| 2933.49.10 | 00 | Ethoxyquin (1,2-Dihydro-6-ethoxy-2,2,4- trimethylquinoline) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 55% |
| 2933.49.15 | 00 | 8-Methylquinoline and Isoquinoline | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.49.17 | 00 | Ethyl ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylate | kg | Free | | 15.4￠/kg + 52% |
| 2933.49.20 | 00 | 5-Chloro-7-iodo-8-quinolinol (Iodochlorhydroxyquin); Decoquinate; Diiodohydroxyquin; and Oxyquinoline sulfate | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 46% |
| 2933.79.20 | 00 | N-Methyl-2-pyrrolidone; and 2-Pyrrolidone | kg | 4.2% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P,SG) | 25% |
| 2933.79.30 | 00 | N-Vinyl-2-pyrrolidone, monomer | kg | 5.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 40% |
| 2933.99.08 | 00 | Acetoacetyl-5-aminobenzimidazolone; 3-(2H-Benzotriazol-2-yl)-5-(tert-butyl)-4- hydroxybenzene propanoic acid, C7-C9 branched or linear alkyl esters; 2-(2H-Benzotriazol-2-yl)-6-dodecyl-4- methyl phenol, in liquid form, branched and linear; and 1,3,3-Trimethyl-2-methyleneindoline | kg | Free | | 15.4￠/kg + 52% |
| 2933.99.12 | 00 | 6-Bromo-5-methyl-1H-imidazo[4,5-b]- pyridine; 2-sec-Butyl-4-tert-butyl-6-(benzotriazol-2- yl)phenol; 2-tert-Butyl-4-methyl-6-(5-chlorobenzotri- azol-2-yl)phenol; 2,4-Di-tert-butyl-6-(benzotriazol-2-yl)phenol; 2,4-Di-tert-butyl-6-(5-chlorobenzotriazol-2- yl)phenol; 2,3-Dichloro-6-quinoxalinecarbonyl chloride; 1-Hydroxy-2-carbazolecarboxylic acid; 2-Hydroxy-3-carbazolecarboxylic acid; 2-Hydroxy-3-carbazolecarboxylic acid, sodium salt; Iminodibenzyl(10,11-dihydro-5H-dibenz- [b,f]azepine); Indoline; 3-Methylbenzo[f]quinoline; 2-Methylindoline; 2-Methylmercaptobenzimidazole; 1-Methyl-2-phenylindole; 1-Methylpyrazine; 2,4-Methylpyrazolic acid; 2-Phenylbenzimidazole; 2-Phenylindole; Tetramethylpyrazine; 2,3,5-Triphenyltetrazolium chloride; dl-Tryptophan; and Vinylcarbazole, monomer | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2934.10.70 | 00 | 4,5-Dichloro-2-n-octyl-4-isothiazolin-3-one; Ethyl 2-(2-aminothiazol-4-yl)-2- hydroxyiminoacetate; Ethyl 2-(2-aminothiazol-4-yl)-2- methoxyiminoacetate; 2-Methyl-4-isothiazolin- 3-one; 2-n-Octyl-4-isothiazolin-3-one; and Thiothiamine hydrochloride | kg | Free | | 30.5% |
| 2934.91.00 | 00 | Aminorex (INN), brotizolam (INN), clotiazepam (INN), cloxazolam (INN), dextromoramide (INN), haloxazolam (INN), ketazolam (INN), mesocarb (INN), oxazolam (INN), pemoline (INN), phendimetrazine (INN), phenmetrazine (INN) and sufentanil (INN); salts thereof | kg | Free | | 15.4￠/kg + 52% |
